LAUSR

Hydroquinone (HQ), one of the metabolites of benzene in humans, has significant hepatotoxic properties. Chronic exposure to HQ can lead to leukemia. In a previous study by this group, we constructed a model of malignant transformation of human lymphoblastoid cells (TK6) induced by chronic exposure to HQ with significant subcutaneous tumorigenic capacity in nude mice. miR‐92a‐3p is a tumor factor whose role in HQ‐induced malignant transformation is not yet clear. In the present study, raw signal analysis and dual‐luciferase reporter gene results suggested that miR‐92a‐3p could target and regulate TOB1, and the expression level of miR‐92a‐3p was significantly upregulated in the long‐term HQ‐induced TK6 malignant transformation model, while the anti‐proliferative factor TOB1 was significantly downregulated. To investigate the mechanism behind this, we inhibited miR‐92a‐3p in a malignant transformation model and found a decrease in cell viability, a decrease in MMP‐9 protein levels, a G2/M phase block in the cell cycle, and an upregulation of the expression of G2/M phase‐related proteins cyclinB1 and CDK1. Inhibition of miR‐92a‐3p in combination with si‐TOB1 restored cell viability, inhibited cyclin B1 and CDK1 protein levels, and attenuated the G2/M phase block. Taken together, miR‐92a‐3p reduced the cell proliferation rate of HQ19 and caused cell cycle arrest by targeting TOB1, which in turn contributed to the altered malignant phenotype of the cells. This study suggests that miR‐92a‐3p is likely to be a biomarker for long‐term HQ‐induced malignant transformation of TK6 and could be a potential therapeutic target for leukemia caused by long‐term exposure to HQ.